Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma

Clinical trial NCT06708650 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06708650
Sponsor: Guiping People's Hospital
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Radiotherapy PD-1 Inhibitors

Start date: 2025-01-01
Primary completion: 2026-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.